1. Home
  2. EVO vs ENVX Comparison

EVO vs ENVX Comparison

Compare EVO & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.53

Market Cap

568.6M

Sector

Health Care

ML Signal

HOLD

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$2.74

Market Cap

612.3M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
ENVX
Founded
1993
2006
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
568.6M
612.3M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
EVO
ENVX
Price
$1.53
$2.74
Analyst Decision
Buy
Buy
Analyst Count
3
12
Target Price
$4.23
★ $9.75
AVG Volume (30 Days)
83.4K
★ 8.7M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 40.94
EPS
★ N/A
N/A
Revenue
N/A
★ $31,821,000.00
Revenue This Year
N/A
$22.89
Revenue Next Year
$20.47
$93.70
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 37.91
52 Week Low
$1.33
$2.20
52 Week High
$4.19
$12.40

Technical Indicators

Market Signals
Indicator
EVO
ENVX
Relative Strength Index (RSI) 45.54 51.14
Support Level $1.50 $2.48
Resistance Level $1.97 $3.01
Average True Range (ATR) 0.05 0.25
MACD 0.02 0.06
Stochastic Oscillator 60.73 74.03

Price Performance

Historical Comparison
EVO
ENVX

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

Share on Social Networks: